Alphabet Starts Euro Bond Sale, Testing Tech Debt Demand
Alphabet has begun selling euro-denominated bonds, testing investor interest in the technology sector's debt market.
Related stories
Check Point Software Shares Fall 6.6% Premarket After Q3 Revenue Miss
M impact | EQUITY | Nov 02, 2026, 11:45 AM UTC
Maritime Launch Services Receives Final Approval to List on TSX
The company’s common shares are set to begin trading on the TSX on November 3 under the symbol MAXQ.
L impact | EQUITY | Nov 02, 2026, 11:45 AM UTC
Entergy Reports Q3 Operating Revenue of $4.37 Billion
Entergy reported Q3 operating revenue of $4.37 billion, versus a FactSet estimate of $4.12 billion.
M impact | EQUITY | Nov 02, 2026, 11:44 AM UTC
Granules India Q2 profit rises nearly 40% as sales offset costs
The Indian drugmaker reported a nearly 40% increase in second-quarter profit, with new product launches and strong overseas sales of its main medicines outweighing higher productio
M impact | EQUITY | Nov 02, 2026, 11:44 AM UTC
Agenus Reports 100% Major Pathologic Response in dMMR Combination Cohort
In the 14-patient dMMR/MSI-H BOT+BAL cohort, all patients achieved a major pathologic response and 13 (93%) achieved a complete response. At the February 9, 2026 cutoff, no BOT+BAL
M impact | EQUITY | Nov 02, 2026, 11:43 AM UTC
Agenus BOT+BAL Meets Primary Endpoint in Phase 2 Colon Cancer Trial
Agenus said its BOT+BAL treatment met the primary endpoint in a Phase 2 trial in microsatellite-stable colon cancer.
M impact | EQUITY | Nov 02, 2026, 11:43 AM UTC